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Abstract
Pancreatic lymphoepithelial cysts are rare, benign, non-neoplastic unilocular or multilocular cystic lesions. These
circumscribed pancreatic lesions are filled with keratinous material grossly and exhibit distinct microscopic features.
Pancreatic lymphoepithelial cysts are like the more common lymphoepithelial cysts of the parotid glands, which have been
associated with the diffuse infiltrative lymphocytosis syndrome often seen in patients with HIV infection. However, pancreatic
lymphoepithelial cysts are rare and their association with HIV infection has not been established. The presence of secondary
changes in non-neoplastic cysts such as goblet cell metaplasia that was present in our case is an important feature to be
included in the differential diagnosis and not to be interpreted as a mucinous neoplasm, particularly on fine-needle aspiration
specimen microscopic evaluation that would impact further management. Here we describe the diagnosis and treatment of
lymphoepithelial cysts in a patient who was on highly active antiretroviral therapy for HIV infection and we provide a brief
literature review. Defining the clinical characteristics of lymphoepithelial cysts in patients with HIV and determining accurate
preoperative diagnostic procedures will be critical for establishing effective surgical and medical approaches to treating these
cysts, which differ substantially from other more serious pancreatic cystic lesions.
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Introduction
Pancreatic cystic lesion (PCL) comprises a broad group of
lesions, both neoplastic and non-neoplastic, that are being
increasingly detected by imaging studies. Most cystic pancreatic lesions are non-neoplastic and pseudocysts are the
most commonly seen. Lymphoepithelial cysts (LEC) of the
pancreas are rare, benign, non-neoplastic unilocular or multilocular circumscribed cystic lesions. They are lined with
mature stratified squamous epithelium, surrounded by a
dense band of mature lymphoid tissue with occasional prominent well-formed germinal centers, and filled with keratinous content.1 Pancreatic LEC are morphologically similar
to the LEC of the salivary gland that often occur in the
parotid gland. These parotid LEC are strongly associated
with a diffuse infiltrative lymphocytosis syndrome seen in
patients with HIV infection.2

The first report of a patient with pancreatic LEC was
described by Lüchtrath and Schriefers in 1985.3 Pancreatic
LEC constitute less than 0.5% of non-neoplastic lesions4 and
are often difficult to differentiate from other pancreatic cystic
neoplasms clinically, radiologically, and preoperatively. The
etiopathogenesis of pancreatic LEC is not well understood
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Figure 1. Contrast-enhanced abdomen and pelvis computed
tomography scan (CT). Axial CT image—dotted arrow shows a
septated and cystic lesion within the pancreatic body to the left
of the midline.

and the association of pancreatic LEC with HIV infection is
highly uncommon and has been regarded as mere a coincidental finding. Of approximately 100 previously reported
cases of pancreatic LEC, only two included patients had concurrent HIV infection.5 Thus, the association of pancreatic
LEC in patients with HIV infection has not been established
because of limited historical reports and the non-specific features of some benign cyst that may mimic neoplastic lesions.
These challenges could lead to delayed diagnosis and unnecessary medical interventions, and more information is needed
to establish clear clinical procedures for accurately identifying and effectively treating pancreatic LEC in patients with
HIV. Here, we report a case of pancreatic LEC within the
setting of HIV infection and provide a brief literature review
of cases reported within this clinical context.

Case report
A 53-year-old man who was receiving highly active antiretroviral therapy for HIV infection presented to the emergency
department for recurrent rectal abscess. The patient had type
2 diabetes and did not have a history of acute or chronic pancreatitis. An abdominopelvic computed tomography scan
revealed an incidental 2.8 cm cystic lobulated exophytic
lesion without associated calcifications within the pancreatic
body, which was suspected to be a neoplasm (Figure 1).
Magnetic resonance imaging of the pancreatic lesion
revealed a T2 hyperintense, T1 hypointense cystic mass with
a few thin septations in the distal pancreatic body. There
were no mural nodules or enhancement noted, and the mass
had no obvious communication with the main pancreatic
duct. The patient also had an elevated carbohydrate antigen
19-9 value (CA 19-9) of 59.1 U/mL (reference < 45.1 U/mL)
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and an unremarkable pancreatic cyst fluid carcinoembryonic
antigen (CEA) of 2.4 ng/mL. The patient underwent further
workup, including endoscopic ultrasonography and a fineneedle aspiration (EUS-FNA) of the lesion. The fine-needle
aspiration cytology showed bland epithelial cells with vacuolated intracytoplasmic mucin and scattered lymphocytes as
well as benign squamous epithelium (Figure 2); therefore,
the differential diagnosis included a mucinous cystic neoplasm, among others. Because of the working diagnosis of a
mucinous cystic neoplasm as determined by the radiological
and cytological evaluations, a distal pancreatosplenectomy
was performed. Macroscopic examination of the surgical
specimen revealed a 3.1 × 2.4 × 2.3 cm tan-yellow, well-circumscribed cystic mass filled with serous to caseous secretions. Microscopic examination of the specimen showed a
cyst lined by mature stratified squamous epithelium with
foci of goblet cell metaplasia, surrounded by dense lymphoid
tissue (Figure 3). The cyst cavity was filled with keratinous
debris and all pathological analyses were consistent with a
benign pancreatic LEC.

Discussion
PCLs are common and recent technological advances in
imaging modalities have increased our ability to detect them.
As a result of improved imaging techniques developed over
the last three decades, the clinical, radiological, and pathological features of many PCLs have been better characterized. Cystic pancreatic lesions are broadly categorized as
non-neoplastic or neoplastic,6 and majority are non-neoplastic, with pseudocysts being the most seen non-neoplastic
lesion. Since cystic pancreatic lesions are increasingly being
detected by imaging techniques, we need defining clear, safe
diagnostic procedures and exploring whether surgical or
medical treatment approaches work best. EUS-FNA of pancreatic cysts with fluid characterization, including cytologic
assessment as well as biochemical marker analysis (e.g.
CEA, CA19-9 and amylase), do have diagnostic limitations.
The diagnostic accuracy of CEA as a tumor marker is poor in
assessing malignant pancreatic cysts with reported sensitivity and specificity of approximately 63%.7 The addition of
DNA-based molecular testing of pancreatic cyst fluid using
next-generation sequencing technique for detection of KRAS,
GNAS, RNF43, SMAD4, and TP53 mutations can further aid
diagnostic accuracy preoperatively and risk stratification of
PCL.8 Various meta-analysis studies have revealed overall
high specificity and low sensitivity of EUS-FNA-based
cytology in differentiating mucinous from non-mucinous
pancreatic cysts,9 with a variable sensitivity of 35%–63%
and specificity of 83%–99%.10–12 One of the recent innovations to improve diagnostic accuracy of PCL is the use of
endoscopic ultrasonography-guided through-the-needle
biopsy (EUS-TTNB). By inserting a micro-forceps device
through a 19-gauge needle, this technique enhances tissue
sampling of PCL and thus leads to a more definitive
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Figure 2. (a) Romanowsky stain ×200—bland epithelial cells with intracytoplasmic mucin and few scattered lymphocytes. (b)
Papanicolaou stain ×100—benign squamous component.

Figure 3. (a) Hematoxylin and eosin ×100—cyst wall lined by mature stratified squamous epithelium and a band of lymphocytes with
foci of goblet cell metaplasia. (b) Hematoxylin and eosin ×400—focus of goblet cell metaplasia.

diagnosis and decrease in interobserver variability.13,14 A
recent study showed that EUS-TTNB has a higher diagnostic
yield in the preoperative assessment of PCL than the combination of EUS-FNA cytology and fluid CEA.15
Pancreatic neoplastic cysts can be subclassified into two
categories: mucinous (intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, and intraductal oncocytic papillary neoplasms) and non-mucinous (serous
cystadenomas).6,16 Non-neoplastic pancreatic cysts are usually injury-related and/or inflammation-related, and these
are seen in approximately 30%–40% of patients with chronic
pancreatitis. Other non-neoplastic cysts include congenital
cysts, LEC, and squamoid cysts of the pancreatic duct
(SCOPD), among others. In general, mucinous pancreatic
neoplasms have serious clinical implications, as they possess
malignant potential representing the adenoma-adenocarcinoma sequence,16 whereas non-mucinous neoplastic cysts do
not appear to harbor malignant potential. Also, in assessing
PCL, the rare occurrence of degenerative or necrotic changes
in non-mucinous solid malignant tumors such as cystic
degeneration in ductal adenocarcinoma and neuroendocrine

tumors must be considered, since these are malignant, with
variable degrees of aggressiveness.16 In addition, the presence of secondary changes in non-neoplastic cysts such as
goblet cell metaplasia that was present in our case is an
important feature to be included in the differential diagnosis
and not to be interpreted as a mucinous neoplasm, particularly on fine-needle aspiration specimens that would impact
further patient management. To our knowledge, this is the
first case of pancreatic LEC that demonstrated such metaplastic features.
LEC have been described in various anatomic locations
and within different human organs, including the parotid
gland, thyroid, parathyroid, lung, thymus, and rarely in the
pancreas.4,17,18 Pancreatic LEC are rare cystic lesions that
have an undetermined pathogenesis and are predominant in
men.3,4 A potential pitfall in the accurate diagnosis of benign
pancreatic LEC is that the cyst fluid may harbor elevated
levels of carbohydrate antigen 19-9, and rarely, elevated levels of CEA; however, cysts with these features have no
malignant potential as shown in the previous case reports
and literature review.18 Furthermore, a small biopsy sample
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of the dense lymphoid stroma that contains limited tissue
may falsely suggest the possibility of a lymphoproliferative
disorder or as in our case, the rare finding of goblet cell
metaplasia led to the diagnostic consideration of mucinous
neoplasm on the EUS-FNA specimen.
Pancreatic LEC are rarer than parotid gland LEC, with
less than 100 patient reports documented in the literature,
including only two associated with an HIV infection.5
Exploration into a possible association of pancreatic LEC
with HIV infection might be warranted since the parotid
gland and the pancreas are similar in many ways: both being
accessory organs of the human digestive system, and furthermore, they are both exocrine and endocrine organs with similar structure, physiologic function, and embryological
development.19,20 In addition, the progenitor cells of the pancreas and parotid glands have similar roles in repair and
regeneration.19–21 Bédat et al.5 emphasized the similarity and
correlation between the pancreatic and the parotid gland
LEC. However, the pathogenesis of pancreatic LEC remains
largely unknown. Of the possible mechanisms proposed in
the pathogenesis, one is that LEC may occur as a consequence of antigens or expression of mediators acting on the
ductal epithelium, which has an affinity for lymphoid cells,
resulting in massive lymphoid infiltration and growth induction from the factors that lymphoid cells mediate.4
Alternatively, development of a remnant of epithelium
within the lymph nodes may occur, and this model was substantiated by Arai et al.22 in their identification of LEC precursors within peripancreatic lymph nodes.4,23 However, one
factor arguing against this theory of pathogenesis is that LEC
lack unique lymph node features, such as sinuses and a capsule.4 Finally, it has been suggested that pancreatic LEC may
originate from displaced branchial cleft cysts fused with pancreatic tissues during embryogenesis.3,4,24

Conclusion
Our patient’s case and the other few reported cases suggest
the possible association of benign pancreatic LEC with HIV
infection, similar to what has been described for the parotid
gland LEC. Our case also highlights that although rare, secondary changes, including goblet cell metaplasia, may occur
in pancreatic LEC and therefore this entity should be
included in the differential diagnosis of cystic lesions of the
pancreas since the management can be non-surgical.
Additional studies and follow-up are needed to establish
potential association with HIV and goblet cell metaplasia in
pancreatic LEC.
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